SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Mitochondrial DNA Analysis from Exome Sequencing Data Improves Diagnostic Yield in Neurological Diseases

Poole, OV; Pizzamiglio, C; Murphy, D; Falabella, M; Macken, WL; Bugiardini, E; Woodward, CE; Labrum, R; Efthymiou, S; Salpietro, V; et al. Poole, OV; Pizzamiglio, C; Murphy, D; Falabella, M; Macken, WL; Bugiardini, E; Woodward, CE; Labrum, R; Efthymiou, S; Salpietro, V; Chelban, V; Kaiyrzhanov, R; Maroofian, R; SYNaPS Study Group; Amato, AA; Gregory, A; Hayflick, SJ; Queen Square Genomics; Jonvik, H; Wood, N; Houlden, H; Vandrovcova, J; Hanna, MG; Pittman, A; Pitceathly, RDS (2021) Mitochondrial DNA Analysis from Exome Sequencing Data Improves Diagnostic Yield in Neurological Diseases. Ann Neurol, 89 (6). pp. 1240-1247. ISSN 1531-8249 https://doi.org/10.1002/ana.26063
SGUL Authors: Maroofian, Reza Pittman, Alan Michael

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (458kB) | Preview
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

A rapidly expanding catalog of neurogenetic disorders has encouraged a diagnostic shift towards early clinical whole exome sequencing (WES). Adult primary mitochondrial diseases (PMDs) frequently exhibit neurological manifestations that overlap with other nervous system disorders. However, mitochondrial DNA (mtDNA) is not routinely analyzed in standard clinical WES bioinformatic pipelines. We reanalyzed 11,424 exomes, enriched with neurological diseases, for pathogenic mtDNA variants. Twenty‐four different mtDNA mutations were detected in 64 exomes, 11 of which were considered disease causing based on the associated clinical phenotypes. These findings highlight the diagnostic uplifts gained by analyzing mtDNA from WES data in neurological diseases.

Item Type: Article
Additional Information: © 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association. This is an open access article under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
Keywords: SYNaPS Study Group, Queen Square Genomics, 1103 Clinical Sciences, 1109 Neurosciences, Neurology & Neurosurgery
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Ann Neurol
ISSN: 1531-8249
Language: eng
Dates:
DateEvent
16 May 2021Published
1 April 2021Published Online
8 March 2021Accepted
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
UNSPECIFIEDAtaxia UKUNSPECIFIED
UNSPECIFIEDBrain Research UKUNSPECIFIED
MR/S002065/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
MR/S005021/1Medical Research Councilhttp://dx.doi.org/10.13039/501100000265
UNSPECIFIEDMultiple System Atrophy TrustUNSPECIFIED
UNSPECIFIEDMuscular Dystrophy AssociationUNSPECIFIED
UNSPECIFIEDMuscular Dystrophy UKUNSPECIFIED
UNSPECIFIEDNational Institute for Health ResearchUNSPECIFIED
UNSPECIFIEDRosetrees TrustUNSPECIFIED
Wellcome Trust Synaptopathies AwardWellcome Trusthttp://dx.doi.org/10.13039/100004440
PubMed ID: 33704825
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113089
Publisher's version: https://doi.org/10.1002/ana.26063

Actions (login required)

Edit Item Edit Item